Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (34) clinical trials

The purpose of this research study is to investigate brain changes in adolescents whoa re currently experiencing Attention Deficit Hyperactivity Disorder (ADHD) symptoms and have a family history of bipolar disorder. Participants will be randomized to mixed amphetamine salts or placebo for 12-week treatment.

Phase N/A

The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing ADHD symptoms. Participants will be given mixed amphetamine salts for a 12-week treatment period.

Phase N/A

Is your child easily distracted? Is it hard for him to pay attention or wait his turn? Is it difficult for him to sit down to work without fidgeting or jumping up to do something else? Does he often act first and think later? Do these behaviors affect how he ...

Phase

Evaluate pediatric patients with ADHD

Phase N/A

Clinical Trials of Texas, Inc. is conducting an investigational study for Aggression in Teenagers with ADHD. Signs of aggression include but are not limited to: fighting, throwing tantrums, and getting in trouble at school. Teens must currently be on ADHD medications.  

Phase N/A

The purpose of this study is to evaluate the effect of SPN-810 for the treatment of impulsive aggression (IA) in adolescents diagnosed with ADHD when taken in conjunction with standard ADHD treatment.  

Phase

The purpose of this study is to evaluate the effect of 4-week SPN-810 treatment on brain functioning in patients aged 8-12 years with ADHD and associated feature of IA. This will be achieved using functional magnetic resonance imaging (fMRI) in conjunction with the point subtraction aggression paradigm (PSAP) Task, a ...

Phase

Children between the ages of 6-12 years who are diagnosed with impulsive aggression comorbid with ADHD and have participated in the 810P301 or 810P302 study are invited to participate in this study. This is a Phase 3 open label extension (OLE) study with the objective of collecting long-term safety data ...

Phase

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old).

Phase